Please login to the form below

Not currently logged in
Email:
Password:

US

This page shows the latest US news and features for those working in and with pharma, biotech and healthcare.

Menlo slumps as itching drug fails mid-stage trial

Menlo slumps as itching drug fails mid-stage trial

Shares in the US biotech closed down almost a third after the announcement, which indicated neurokinin-1 antagonist serlopitant had missed all the primary and secondary endpoints in the 233-patient ... may have CPUO – defined as itching lasting six

Latest news

More from news
Approximately 189 fully matching, plus 5,788 partially matching documents found.

Latest Intelligence

  • Can protein degraders unlock ‘undruggable’ drug targets? Can protein degraders unlock ‘undruggable’ drug targets?

    Clinical candidates. US biotech Arvinas – founded by protein degrader pioneer Craig Crews of Yale University – seems to be out in front in the emerging field at the moment, starting a phase

  • BRIC markets BRIC markets

    US drug prices are often used as a direct or indirect reference for products sold in BRIC markets. ... As a result US government efforts to reduce pharmaceutical prices is likely to have an impact.”.

  • Novo Nordisk awakens its ‘Sleeping Beauty’ Novo Nordisk awakens its ‘Sleeping Beauty’

    For years physicians were asking us for NovoSeven to be used in bolus pumps to deliver the drug for the long run,” said Helfgott.

  • 20 for 2020 – Five pharma companies to watch 20 for 2020 – Five pharma companies to watch

    There’s also some urgency for the transaction to go quickly and smoothly as AbbVie prepares for the loss of patent protection for $20bn immunology drug Humira (adalimumab) in the US ... In October 2019 J&J was found liable for a whopping $8bn in

  • The roaring ‘20s and Generation Z The roaring ‘20s and Generation Z

    How a new generation will shape pharma comms this decade. 2020 is here and we are naturally now awash with ‘trends’ articles, telling us what to look out for in pharmaceutical ... The advocacy landscape. The other side of the communications coin for

More from intelligence
Approximately 13 fully matching, plus 660 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 766 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 17 fully matching, plus 968 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics